Sanofi India Limited has declared a final dividend of ₹117 per equity share for the financial year ending December 31, 2024, subject to shareholder approval at the upcoming AGM. The dividend will be payable to shareholders whose names appear in the company’s records as of the record date, April 25, 2025.
Sanofi India Board Meeting: Key Decisions Announced
Sanofi India Limited has announced several key decisions following its Board of Directors meeting held on March 18, 2025. The company, a leading pharmaceutical player, disclosed its plans regarding dividend distribution, an upcoming Annual General Meeting (AGM), and a director’s re-appointment.
Annual General Meeting Scheduled for May 15, 2025
The company will hold its 69th AGM on May 15, 2025, at 3:30 PM via video conferencing (VC) and other audio-visual means (OAVM). This move ensures shareholder participation while maintaining flexibility in remote engagement.
Final Dividend of ₹117 per Share Announced
In line with its previous intimation on February 27, 2025, Sanofi India’s Board has confirmed a final dividend of ₹117 per equity share (face value of ₹10 each) for the financial year ending December 31, 2024. The dividend payment is contingent upon approval by the shareholders at the AGM. Shareholders holding shares as of April 25, 2025, will be eligible for the payout, with NSDL and CDSL providing the final beneficiary details.
Re-Appointment of Independent Director
Sanofi India’s Board has approved the re-appointment of Mr. Rahul Bhatnagar as an Independent Director for a second term of five years, from July 29, 2025, to July 28, 2030. His re-appointment is subject to shareholder approval via a special resolution at the AGM.
Mr. Bhatnagar, a Chartered Accountant and MBA from Wharton, has over four decades of experience across FMCG, telecommunications, insurance, consulting, and real estate sectors. He has previously held leadership roles at PepsiCo, Bharti Enterprises, and Seagram. He currently serves as an Independent Director on the boards of Whirlpool of India Limited, Rossell India Limited, TBO TEK Limited, and Tasty Bites Eatables Limited.
Conclusion
Sanofi India’s latest announcements reflect its commitment to rewarding shareholders, maintaining strong corporate governance, and ensuring experienced leadership at the helm. Investors and stakeholders will be closely watching the AGM proceedings for further updates on the company’s future strategy.
Disclaimer: This content is about(US stock market) intended solely for educational and informational purposes and should not be interpreted as financial or investment advice. The information presented is derived from publicly available sources and independent analysis; however, its accuracy or completeness is not guaranteed. Readers are encouraged to conduct their own due diligence and seek guidance from a professional financial advisor before making any investment decisions. Neither the author nor stoxmail.com assumes responsibility for any financial losses or investment actions taken based on this article.